European Archives - Page 13 of 1370 - European Medical Journal

Pallidal Beta Power Linked to Depression in Parkinson’s

Pallidal Beta Power Linked to Depression in Parkinson’s

Elevated pallidal beta power may serve as a biomarker for depression in Parkinson’s disease, paving the way for targeted DBS therapies. Learn more.

Acne Risk Rises Markedly After Gender-Affirming Hormone Therapy

Acne Risk Rises Markedly After Gender-Affirming Hormone Therapy

Acne risk rises sharply in transmasculine individuals starting testosterone and also affects transfeminine patients on estradiol. Read more.

What are the Risks of Deep Brain Stimulation?

Discover why deep brain stimulation may be safer than expected and how large scale data could change surgical decision making.

Machine Learning Aids Prognosis in Upper Tract Urothelial Cancer

Machine learning models accurately predict survival after surgery for upper tract urothelial cancer, supporting personalised follow up and adjuvant treatment decisions.

Hidden Mpox Exposure Found Among Healthy Adults

New sero-genomic research suggests hidden mpox exposure in healthy Nigerian adults, highlighting residual smallpox immunity and surveillance gaps.

CAR-T Cell Therapy Induces Durable Remission in SLE

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients with severe, treatment-refractory systemic lupus erythematosus.

Optimising Continuous Infusion Therapy in Advanced Parkinson’s Disease

This infographic offers consensus-based guidance on the real-world use of LDp/CDp for patients with advanced…

Hetrombopag Effective in Paediatric Immune Thrombocytopenia

Hetrombopag achieved an overall response in over three quarters of paediatric patients with immune thrombocytopenia, with durable responses and no serious adverse events reported.

New Rule for Predicting Postoperative Atrial Fibrillation

MPO concentrations in selectively drained pericardial fluid were 25-fold higher than mixed drainage samples and 1,648-fold higher than serum levels (both p

New Blood Marker Predicts Future Asthma Attacks

Sphingolipid-to-steroid ratios in blood accurately predict asthma attacks years in advance, offering a new precision medicine tool for asthma care.